These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 5861160)

  • 21. An antibody induction method in mice for the potency assays of diphtheria and tetanus components in combined vaccines.
    Maheshwari SC; Sharma SB; Kumar A; Sokhey J
    J Commun Dis; 1998 Sep; 30(3):139-46. PubMed ID: 10093418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological methods for potency testing of tetanus toxoid vaccines for human use.
    Hendriksen C; Winsnes R
    Dev Biol (Basel); 2002; 111():131-40. PubMed ID: 12678232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Procoagulatory activity of macrophages and monocytes of the guinea pig].
    Gaertner HJ; Flössel C; Müller M
    Biomed Biochim Acta; 1984; 43(4):429-38. PubMed ID: 6207811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody production following immunization with diphtheria and tetanus toxoids in children receiving chemotherapy during remission of malignant disease.
    Kung FH; Orgel HA; Wallace WW; Hamburger RN
    Pediatrics; 1984 Jul; 74(1):86-9. PubMed ID: 6588361
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antitetanus and antidiphtheria immunity in newborns.
    Durbacă S
    Roum Arch Microbiol Immunol; 1999; 58(3-4):267-72. PubMed ID: 11845464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary response to tetanus toxoid stimulation in early infancy].
    Rosaschino F; Cisarri G; Torre R; Salvini F; Corti G
    Minerva Pediatr; 1995 Mar; 47(3):65-71. PubMed ID: 7791714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deficiencies in tetanus prophylaxis in wound management in Ibadan, Nigeria.
    Fatunde OJ; Familusi JB
    West Afr J Med; 2002; 21(2):105-7. PubMed ID: 12403028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of tetanus antitoxin titers of sera from immunized mice and guinea pigs determined by toxin neutralization test and enzyme-linked immunosorbent assay.
    Gupta RK; Siber GR
    Biologicals; 1994 Sep; 22(3):215-9. PubMed ID: 7811454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of oil adjuvant and aluminium phosphate-adsorbed toxoid for the passive immunization of lambs against tetanus.
    Cameron CM; Van Biljon BJ; Botha WJ; Knoetze PC
    Onderstepoort J Vet Res; 1983 Sep; 50(3):229-31. PubMed ID: 6646665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potency tests of diphtheria, tetanus and combined vaccines. Suggestion for a simplified potency assay.
    Aggerbeck H; Heron I
    Dev Biol Stand; 1996; 86():297-301. PubMed ID: 8785958
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Determination of bulk proteins in tetanus toxoid using the passive cutaneous anaphylaxis test].
    Künzel W; Meissner C; Gienapp E
    Arch Exp Veterinarmed; 1981; 35(5):757-61. PubMed ID: 7337533
    [No Abstract]   [Full Text] [Related]  

  • 32. Interlaboratory validation of in vitro serological assay systems to assess the potency of tetanus toxoid in vaccines for veterinary use.
    Hendrikson CF; Woltjes J; Akkermans AM; van der Gun JW; Marsman FR; Verschure MH; Veldman K
    Dev Biol Stand; 1996; 86():335. PubMed ID: 8785975
    [No Abstract]   [Full Text] [Related]  

  • 33. On immunogenic properties of tetanus toxoids.
    Bittner J; Stoean C; Cuşa E
    Arch Roum Pathol Exp Microbiol; 1980; 39(1):21-6. PubMed ID: 6996638
    [No Abstract]   [Full Text] [Related]  

  • 34. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Biological characteristics of specific IgE for tetanus toxoid].
    Miadonna A
    Boll Ist Sieroter Milan; 1980 Nov; 59(5):554-9. PubMed ID: 7248090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An approach to establishing diphtheria potency specifications for diphtheria and tetanus toxoid, acellular pertussis vaccine formulations linked to clinical efficacy.
    Brock B; Mckee B
    Biologicals; 1999 Jun; 27(2):183. PubMed ID: 10600210
    [No Abstract]   [Full Text] [Related]  

  • 37. [Relations between the combining power of tetanus anatoxin and its immunogenic capacity].
    Lazár M; Lasco N
    Arch Roum Pathol Exp Microbiol; 1964 Mar; 23(1):159-68. PubMed ID: 5877132
    [No Abstract]   [Full Text] [Related]  

  • 38. A single dose vaccine to prevent neonatal tetanus.
    Dastur FD; Awatramani VP; Chitre SK; D'Sa JA
    J Assoc Physicians India; 1993 Feb; 41(2):97-9. PubMed ID: 8335616
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The foetal immune response to maternal tetanus toxoid immunization.
    Dastur FD; Shastry P; Iyer E; Awatramani V; Raut S; Mehta SD; Irani SF
    J Assoc Physicians India; 1993 Feb; 41(2):94-6. PubMed ID: 8335615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serological response to immunization with tetanus toxoid.
    Setarunnahar ; Hossain A; Khatun R; Parveen S; Ahmad Z; Haleem A; Alam SK
    Bangladesh Med Res Counc Bull; 2000 Apr; 26(1):15-22. PubMed ID: 11192490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.